About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Effect of Magnesium Supplementation in COPD

Effect of Magnesium Supplementation in COPD

NCT02680769·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Giuseppe Sergi, MD
CONTACT
00390498218492 giuseppe.sergi@unipd.it

Lead

University of Padova

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults (\>18 years).
Moderate-severe COPD (FEV1 between 30-80% of theorical values).

You may not be if

Already taking magnesium or calcium supplementations.
Severe renal (creatinine clearance\< 30 ml/min) or hepatic decline or presence of other co-morbidities interfering with outcomes (e.g. dementia).
Hypermagnesemia (serum Mg\>1.85 mmol/L).

The record

StatusUnknown

PhaseNo phase

Taking part76

StartedMar 2016

UpdatedJun 13, 2016

Conditions

Pulmonary Disease, Chronic Obstructive

Where1

University of Padova-Geriatrics Section
Padova, PD, Italy